Pronostic Score of Morbidity to Determine Risk of Complications After Endoscopic Submucosal Dissection for Colorectal Lesions
- Conditions
- Polyp of Colon
- Registration Number
- NCT04647266
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The mains complications in colo-rectal dissection are the pain, the delayed bleeding and the perforation and represent around 10%.
Currently, the procedure is realized during a hospitalization with not real recommendation about the time of this.
There is currently no score established for the colo-rectal endoscopic submucosal dissection.
* To develop clinical or mixed prognostic score after endoscopic subcostal dissection for colorectal lesions in Nancy's hospital.
* Allow to obtain an estimation of number of patients required for a larger study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 168
- Patient suffering of lesion relevant of endoscopic submucosal dissection treatment:
- Lesions for which en bloc resection with snare EMR is difficult to apply i/LST-NG, particularly LST-NG (PD) ii/ Lesions showing a VI-type pit pattern iii/ Carcinoma with shallow T1 (SM) invasion Large depressed-type tumors iv/ Large protruded-type lesions suspected to be carcinoma
- Mucosal tumors with submucosal fibrosis
- Sporadic tumors in conditions of chronic inflammation such as ulcerative colitis
- Local residual or recurrent early carcinomas after endoscopic resection Local res Les lésions de plus
- Male or female patients aged ≥ 18 years old
- Patients able to fill in questionnaires written in French
- Suspicion of deep submucosal cancer by analysis of macroscopic appearance (Paris O-III), vascular pattern and pit pattern (SANO IIIB, KUDO Vn)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To develop clinical or mixed prognostic score after endoscopic subcostal dissection for colorectal lesions in Nancy's hospital. From 2016 to 2020
- Secondary Outcome Measures
Name Time Method Allow to obtain an estimation of number of patients required for a larger study From 2016 to 2020
Trial Locations
- Locations (1)
CHRU Brabois
🇫🇷Nancy, Meurthe ET Moselle, France